A director at one of the top clinical-stage biotech companies sold 6,000 insider shares towards the end of January 2026 amid ...

These two EV stocks are hot topics in the automotive industry, but only one is a buy for risk-tolerant investors.

The biggest driver of BigBear.ai's poor financial performance is its reliance on government contracts for the majority of its revenue, as the company noted in its quarterly filing. So, changes in ...

This bioscience company has had promising financials, yet one of its top executives exited her entire direct equity ownership in mid-January 2026.

In 2025, Mastercard paid $11.73 billion in stock buybacks and $2.76 billion on dividends. In its latest quarter, which was the first quarter of fiscal 2026, Visa bought back $3.73 billion in stock and ...